The stock of Inhibrx Inc (INBX) has seen a 2.00% increase in the past week, with a -0.80% drop in the past month, and a -6.90% decrease in the past quarter. The volatility ratio for the week is 1.14%, and the volatility levels for the past 30 days are at 1.19% for INBX. The simple moving average for the last 20 days is 0.95% for INBX stock, with a simple moving average of 26.56% for the last 200 days.
Is It Worth Investing in Inhibrx Inc (NASDAQ: INBX) Right Now?
Company’s 36-month beta value is 2.86.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for INBX is 39.26M, and currently, short sellers hold a 5.60% ratio of that floaft. The average trading volume of INBX on May 10, 2024 was 452.79K shares.
INBX) stock’s latest price update
The stock of Inhibrx Inc (NASDAQ: INBX) has increased by 0.73 when compared to last closing price of 34.44. Despite this, the company has experienced a 2.00% gain in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-02-28 that Inhibrx, Inc. (INBX) came out with a quarterly loss of $1.73 per share versus the Zacks Consensus Estimate of a loss of $1.07. This compares to loss of $0.95 per share a year ago.
Analysts’ Opinion of INBX
SMBC Nikko, on the other hand, stated in their research note that they expect to see INBX reach a price target of $40. The rating they have provided for INBX stocks is “Outperform” according to the report published on March 16th, 2022.
JMP Securities gave a rating of “Mkt Outperform” to INBX, setting the target price at $46 in the report published on September 21st of the previous year.
INBX Trading at -0.62% from the 50-Day Moving Average
After a stumble in the market that brought INBX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -12.82% of loss for the given period.
Volatility was left at 1.19%, however, over the last 30 days, the volatility rate increased by 1.14%, as shares sank -0.94% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -6.24% lower at present.
During the last 5 trading sessions, INBX rose by +2.00%, which changed the moving average for the period of 200-days by +48.12% in comparison to the 20-day moving average, which settled at $34.35. In addition, Inhibrx Inc saw -8.71% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at INBX starting from VIKING GLOBAL INVESTORS LP, who purchase 511,627 shares at the price of $19.35 back on Aug 28 ’23. After this action, VIKING GLOBAL INVESTORS LP now owns 511,627 shares of Inhibrx Inc, valued at $9,899,982 using the latest closing price.
Stock Fundamentals for INBX
Current profitability levels for the company are sitting at:
- -121.79 for the present operating margin
- -0.14 for the gross margin
The net margin for Inhibrx Inc stands at -133.96. The total capital return value is set at -0.87. Equity return is now at value -475.31, with -80.62 for asset returns.
Based on Inhibrx Inc (INBX), the company’s capital structure generated 0.83 points at debt to capital in total, while cash flow to debt ratio is standing at -0.92. The debt to equity ratio resting at 4.8. The interest coverage ratio of the stock is -7.47.
Currently, EBITDA for the company is -218.03 million with net debt to EBITDA at 0.31. When we switch over and look at the enterprise to sales, we see a ratio of 969.86. The receivables turnover for the company is 2.31for trailing twelve months and the total asset turnover is 0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.25.
Conclusion
In a nutshell, Inhibrx Inc (INBX) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
